NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

re: "there will be three arms to look at and no traditional placebo arm "

From clinicaltrials.gov: "two out of three will additionally receive DCVax-L, with the remaining one third receiving a placebo".

So far we've heard that the trial design is questionable, and even if approved the stock price won't go very high because it's no magic bullet.

I'm waiting for someone to post that the technical chart looks weak.